(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Chen, X; Gillooly, KM; Hynes, J; Kiener, PA; Leftheris, K; Lin, S; McIntyre, KW; Norris, DJ; Pandit, CR; Patil-Koota, V; Shuster, DJ; Spergel, S; Tokarski, JS; Turk, LA; Wrobleski, ST; Wu, H; Yang, G | 1 |
| Barczyk, A; Baudelet, D; Body-Malapel, M; Carato, P; Djouina, M; Heloire, VM; Leleu-Chavain, N; Millet, R; Renault, N; Rocha, DE | 1 |
2 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Innate Inflammatory Response
| Article | Year |
|---|---|
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cannabinoids; Cells, Cultured; Cricetinae; Drug Design; Female; Humans; Indoles; Inflammation; Leukocytes, Mononuclear; Ligands; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Conformation; Norbornanes; Pyridones; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2003 |
Benzo[d]thiazol-2(3H)-ones as new potent selective CB
Topics: Anti-Inflammatory Agents; Benzothiazoles; Cannabinoid Receptor Agonists; Colon; Humans; Inflammation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2019 |